Viewing Study NCT06848556


Ignite Creation Date: 2025-12-24 @ 11:17 PM
Ignite Modification Date: 2026-03-20 @ 7:12 PM
Study NCT ID: NCT06848556
Status: TERMINATED
Last Update Posted: 2025-02-27
First Post: 2025-02-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluate the Effect of Tirazamine on Primary Liver Cancer.
Sponsor: Zhejiang Raygene Pharmaceuticals Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module